Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Greenway Medical Technologies Inc Comments On FY 2012 Revenue Guidance-Conference Call
Greenway Medical Technologies Inc announced that overall revenue growth for fiscal 2012 to be in the 25% to 30% range.
Latest Developments for Greenway Medical Technologies Inc
- Greenway Medical Technologies Inc Lowers FY 2013 Guidance
- Greenway Medical Technologies Inc Lowers FY 2013 Guidance
- Greenway Medical Technologies Inc Issues FY 2013 Guidance; EBIT, Net Income And EPS Guidance Below Analysts' Estimates
- Greenway Medical Technologies Inc Raises FY 2012 Revenue Guidance-Conference Call
Latest Key Developments in Healthcare
- NICHII GAKKAN CO Amends Consolidated Mid-year Outlook for FY 2014
- Cryo Save Group NV Appoints Walter van Pottelberge As Chairman To Replace Johan Goossens-DJ
- Feelgood Svenska publ AB to Acquire Hagabadet Holding AB
- Primary Health Properties PLC Announces Proposed Firm Placing And Placing, Open Offer
- Share this
- Link this
- Digg this
Follow Reuters